InSightec’s Focused Ultrasound Shows Early, Positive Data For Disabling Tremor
This article was originally published in The Gray Sheet
Executive Summary
The results are an encouraging sign not only for the company but also for the novel device development model employed by the trial’s sponsor, the Focused Ultrasound Foundation.
You may also be interested in...
Novel Essential-Tremor Treatment Gets US Green Light
The ExAblate Neuro uses targeted ultrasound to destroy brain tissue linked to tremors. It is the first device of its type to gain approval from the US regulator.
News Briefs: Dx Bill Reintroduced; FDA Questions Guided Therapeutics’ LuViva; Study Milestones
Rep. Leonard Lance reintroduced a bill in the House to address flaws in Medicare’s reimbursement system for diagnostics. Guided Therapeutics receives more questions from FDA on the PMA for its LuViva cervical scan. Study news from InSightec, Direct Flow Medical and PLC Systems. More news.
Trial Investigates Focused Ultrasound For Parkinson's Disease Tremor
Clinicians discuss a feasibility trial of InSightec's focused ultrasound technology to reduce tremor related to Parkinson’s disease and a registry to show the effectiveness of focused ultrasound in treating uterine fibroids.